Tackling Racial Disparities in HCV Care

In this live, 45-minute Webinar, expert faculty will discuss key barriers that hinder successful, sustained engagement with HCV treatment and prevention services for Black, indigenous, and persons of color in the United States, and strategies to improve engagement in care across the HCV continuum.

Agenda

Key data on barriers to HCV care and strategies to improve engagement with care in BIPOC populations (35 minutes)

Attendee questions answered by the experts (10 minutes)

Events

Date / Time
Event Details

Faculty

Faculty
Oluwaseun Falade-Nwulia, MBBS

Assistant Professor
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Attending
Division of Infectious Diseases
Johns Hopkins Hospital
Baltimore, Maryland

Faculty
Joseph K. Lim, MD

Professor of Medicine; Director, Clinical Hepatology
Section of Digestive Diseases
Yale University School of Medicine
New Haven, Connecticut

Goal Statement
The goal of this activity is to improve clinicians’ competence in recognizing and combatting racial disparities in care for persons with or at risk of HIV, HBV, and HCV infection.

Target Audience
This program is intended for physicians, pharmacists, registered nurses, and other healthcare providers who provide care for patients with or at risk of HIV, HBV, or HCV.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify the barriers that hinder successful, sustained engagement with HIV and viral hepatitis treatment and prevention services among BIPOC and migrant populations
  • Apply plans to improve engagement across the care continuum for HIV and viral hepatitis by combatting race-related barriers
  • Implement strategies to combat implicit racial biases that affect optimal care of individuals with or at risk of HIV or viral hepatitis

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 0.75 contact hours (0.075 CEUs) of the Accreditation Council for Pharmacy Education. UAN: JA4008176-0000-21-103-L02-P

Type of Activity: Knowledge

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

American Board of Internal Medicine Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.